Eureka AIR delivers breakthrough ideas for toughest innovation challenges, trusted by R&D personnel around the world.

Pinocembrin and cyclodextrin or cyclodextrin derivative inclusion compound

A technology of cyclodextrin and pinacol, applied in the field of medicine, can solve the problems of difficulty in oral administration or injection, insolubility in water, poor oral absorption, etc., and achieves the advantages of clinical application, good safety and good dissolution. Effect

Active Publication Date: 2009-09-23
INST OF MATERIA MEDICA AN INST OF THE CHINESE ACAD OF MEDICAL SCI
View PDF1 Cites 14 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0008] In order to solve the technical problems that pinoquinone is insoluble in water, has poor oral absorption, and is difficult to be administered orally or injected in the prior art, the present invention provides the following technical solutions:

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Pinocembrin and cyclodextrin or cyclodextrin derivative inclusion compound
  • Pinocembrin and cyclodextrin or cyclodextrin derivative inclusion compound
  • Pinocembrin and cyclodextrin or cyclodextrin derivative inclusion compound

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0041] Embodiment 1: Preparation of liquid pinenin hydroxypropyl-β-cyclodextrin inclusion compound solution

[0042] (1) Weigh 40g of hydroxypropyl-β-cyclodextrin, pour it into 400ml of distilled water, and stir to dissolve;

[0043] (2) Another 1 g of pinocin was weighed, dissolved in 20 ml of absolute ethanol, and poured into the above-mentioned hydroxypropyl-β-cyclodextrin solution;

[0044] (3) The mixed solution was stirred at 40-50° C. for 20 minutes by magnetic stirring method, and the solution was observed until it was clear and transparent, and the clathrate solution of pinenin hydroxypropyl-β-cyclodextrin derivative was obtained.

Embodiment 2

[0045] Example 2: Preparation of solid pinenin hydroxypropyl-β-cyclodextrin inclusion compound

[0046] (1), (2), (3) are the same as embodiment 1.

[0047] (4) Freeze-drying the clathrate solution of the pinacetin hydroxypropyl-β-cyclodextrin derivative to obtain a solid pinacetin hydroxypropyl-beta-cyclodextrin inclusion complex.

Embodiment 3

[0048] Embodiment 3: Preparation of solid pinenin hydroxypropyl-β-cyclodextrin inclusion compound

[0049] (1) Weigh 20g of hydroxypropyl-β-cyclodextrin, put it into a mortar, add 100ml of distilled water, and grind to make a paste;

[0050] (2) Another 3 g of pinocin was weighed, dissolved in 20 ml of absolute ethanol, and the solution was poured into the above-mentioned hydroxypropyl-β-cyclodextrin solution;

[0051] (3) Grinding the mixed liquid for 2 hours to obtain a uniform paste, filtering, and evaporating to dryness under reduced pressure to obtain a solid clathrate of pinasin cyclodextrin derivatives.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention discloses a pinocembrin and cyclodextrin or cyclodextrin derivative inclusion compound, wherein cyclodextrin or a cyclodextrin derivative is used to include the pinocembrin. The inclusion compound contains the pinocembrin and the cyclodextrin or cyclodextrin derivative in a molar ratio of 1:1-100. The inclusion compound can improve the water solubility of the pinocembrin and give good play of the therapeutic action of the pinocembrin. The inclusion compound is suitable for the preparation of sold dosage forms and liquid dosage forms required by clinics, including infusion solution, water injection, powder injection, oral solution, syrup, tablets, capsules, granules and dispersible tablets. The inclusion compound can be used for preparing drugs for preventing and\or treating cardiovascular and cerebrovascular diseases, particularly brain stroke, as well as drugs for preventing and\or treating bacterial and\or fungal infections.

Description

technical field [0001] The present invention relates to clathrates of pinustin cyclodextrin or cyclodextrin derivatives, a preparation method thereof, pharmaceutical compositions containing such clathrates of pinustin cyclodextrins or cyclodextrin derivatives and in the preparation of medicines the use of. It belongs to the field of medical technology. Background technique [0002] Pinocembrin, also known as pinocembrin, pinocin, chemical name 5,7-dihydroxyflavanone (5,7-Dihydroxyflavanone), 2,3-dihydro-5,7-dihydroxy-2- Phenyl-4H-1-benzopyran-4-one (2,3-Dihydro-5,7-dihydroxy-2-phenyl-4H-1-benzopyran-4-one), is a water-insoluble Dihydroflavonoids, the structure is as follows: [0003] [0004] There is a chiral center in the chemical structure of pinine, the three-dimensional structure of natural pinine is S configuration, and the specific rotation [α] D 15 It is -45.3 (c, 0.9, acetone is the solvent). [0005] (S)-pinoquinone is a natural product extracted from prop...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
IPC IPC(8): A61K47/48A61K31/352A61K47/40A61P9/00A61P9/10A61P31/10A61K47/61
Inventor 吴松杜冠华戚燕高梅杨庆云光红梅李薇王月华童元峰
Owner INST OF MATERIA MEDICA AN INST OF THE CHINESE ACAD OF MEDICAL SCI
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com